 |
February 2021
Destiny Pharma presents an overview of the Company at the Shares Spotlight Investor Evening |
 |
January 2021
Neil Clark talks to Proactive London’s Katie Pilbeam about the XF-73 Phase 2b clinical trial which is now fully recruited |
 |
January 2021
Destiny Pharma presents at the Proactive One2One live investment forum |
 |
January 2021
Proactive ONE2ONE Investor Forum – Thursday January 21st from 6:00 pm GMT |
